Aware Super Pty Ltd as trustee of Aware Super increased its stake in shares of MercadoLibre, Inc. (NASDAQ:MELI – Free Report) by 10.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,993 shares of the company’s stock after purchasing an additional 761 shares during the quarter. Aware Super Pty Ltd as trustee of Aware Super’s holdings in MercadoLibre were worth $20,891,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the stock. Key Financial Inc purchased a new position in shares of MercadoLibre in the 1st quarter valued at about $25,000. GW&K Investment Management LLC purchased a new stake in shares of MercadoLibre during the first quarter worth approximately $25,000. Close Asset Management Ltd raised its holdings in MercadoLibre by 366.7% in the first quarter. Close Asset Management Ltd now owns 14 shares of the company’s stock valued at $27,000 after acquiring an additional 11 shares in the last quarter. Brooklyn Investment Group lifted its stake in MercadoLibre by 650.0% in the first quarter. Brooklyn Investment Group now owns 15 shares of the company’s stock worth $29,000 after acquiring an additional 13 shares during the last quarter. Finally, Twin Tree Management LP purchased a new position in MercadoLibre in the first quarter worth approximately $29,000. Hedge funds and other institutional investors own 87.62% of the company’s stock.
MercadoLibre Price Performance
Shares of MELI opened at $2,048.35 on Thursday. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.20 and a quick ratio of 1.18. MercadoLibre, Inc. has a 1-year low of $1,646.00 and a 1-year high of $2,645.22. The stock has a market cap of $103.85 billion, a PE ratio of 50.59, a price-to-earnings-growth ratio of 1.46 and a beta of 1.46. The firm has a fifty day moving average price of $2,348.72 and a 200 day moving average price of $2,345.35.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the stock. Jefferies Financial Group reissued a “hold” rating and issued a $2,800.00 price objective on shares of MercadoLibre in a research report on Tuesday, August 5th. Barclays dropped their target price on MercadoLibre from $3,100.00 to $3,000.00 and set an “overweight” rating on the stock in a report on Wednesday, July 23rd. Cantor Fitzgerald raised their price target on MercadoLibre from $2,700.00 to $2,900.00 and gave the company an “overweight” rating in a research note on Wednesday, September 24th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $2,750.00 price objective on shares of MercadoLibre in a research report on Tuesday, August 5th. Finally, Susquehanna dropped their price objective on MercadoLibre from $2,975.00 to $2,900.00 and set a “positive” rating on the stock in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $2,810.88.
View Our Latest Report on MercadoLibre
About MercadoLibre
MercadoLibre, Inc operates online commerce platforms in the United States. It operates Mercado Libre Marketplace, an automated online commerce platform that enables businesses, merchants, and individuals to list merchandise and conduct sales and purchases digitally; and Mercado Pago FinTech platform, a financial technology solution platform, which facilitates transactions on and off its marketplaces by providing a mechanism that allows its users to send and receive payments online, as well as allows users to transfer money through their websites or on the apps.
Read More
- Five stocks we like better than MercadoLibre
- How to Use the MarketBeat Dividend Calculator
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- 3 Healthcare Dividend Stocks to Buy
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How to find penny stocks to invest and trade
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for MercadoLibre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MercadoLibre and related companies with MarketBeat.com's FREE daily email newsletter.